Vasculitis Clinical Trials

• Prevention of Relapses in PR3-ANCA-Associated Vasculitis
  ClinicalTrials.gov Identifier: NCT00128895 - Recruiting
  ANCA-associated vasculitis
  
• Clinical Trial of Mycophenolate Versus Cyclophosphamide in ANCA Vasculitis
  ClinicalTrials.gov Identifier: NCT00414128 - Recruiting
  Vasculitis
  
• Phase II Study of Methylprednisolone and Xylose Absorption in Children with Hypersensitivity Vasculitis Associated with Connective Tissue Disease
  ClinicalTrials.gov Identifier: NCT00004357 - Recruiting
  Vasculitis, Hypersensitivity; Connective Tissue Diseases; Dermatomyositis; Vasculitis
  
• Hematopoietic Stem Cell Support in Vasculitis
  ClinicalTrials.gov Identifier: NCT00278512 - Recruiting
  Vasculitis
  
• Rituximab to Treat Hepatitis C-Associated Cryoglobulinemic Vasculitis
  ClinicalTrials.gov Identifier: NCT00029107 - Recruiting
  Hepatitis C; Vasculitis
  
• CellCept in p-ANCA Vasculitis
  ClinicalTrials.gov Identifier: NCT00405860 - Recruiting
  MPO-ANCA Vasculitis; Microscopic Polyangiitis
  
• Evaluation of Clinical Efficacy and Immunologic Response After IL-2 Therapy in HCV-Related Vasculitis Patients
  ClinicalTrials.gov Identifier: NCT00574652 - Not yet recruiting
  Cryoglobulinemia Vasculitis
  
• Inflammatory Responses in Normal Volunteers and Patients with Abnormal Immune Responses
  ClinicalTrials.gov Identifier: NCT00001257 - Recruiting
  Healthy; Inflammation; Vasculitis
  
• Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA)
  ClinicalTrials.gov Identifier: NCT00103792 - Recruiting
  Wegener's Granulomatosis; Vasculitis
  
• Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis
  ClinicalTrials.gov Identifier: NCT00104299 - Recruiting
  Vasculitis; Wegener's Granulomatosis
  
• Abatacept in ANCA Associated Vasculitis
  ClinicalTrials.gov Identifier: NCT00482066 - Recruiting
  ANCA-Associated Vasculitis
  
• Comparison of Treatments to Maintain Disease Remission in Patients with Wegener's Granulomatosis and Related Vasculitis Syndromes
  ClinicalTrials.gov Identifier: NCT00004567 - Completed
  Vasculitis; Wegener's Granulomatosis
  
• Steroids and Methotrexate to Treat Systemic Vasculitis
  ClinicalTrials.gov Identifier: NCT00001256 - Completed
  Inflammation; Vasculitis; Wegener's Granulomatosis
  
• Mycophenolate Mofetil Versus Cyclophosphamide in the Induction Treatment of ANCA Associated Vasculitis
  ClinicalTrials.gov Identifier: NCT00301652 - Completed
  Vasculitis; Anti-Neutrophil Cytoplasmic Antibody
  
• Biological Markers in Retinal Vasculitis
  ClinicalTrials.gov Identifier: NCT00050492 - Completed
  Retinal Vasculitis
  
• IMPROVE: Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy in ANCA Associated Systemic Vasculitis
  ClinicalTrials.gov Identifier: NCT00307645 - Terminated
  ANCA Associated Systemic Vasculitis Including Wegener’s; Granulomatosis and Microscopic Polyangiitis and; Renal Limited Vasculitis
  
• Assessment of Patients with Multiple Sclerosis (MS)
  ClinicalTrials.gov Identifier: NCT00001156 - Recruiting
  Herpesviridae Infection; HTLV-I Infection; Multiple Sclerosis; Tropical Spastic Paraparesis; Vasculitis
  
• Cyclophosphamide and Prednisone Followed by Methotrexate To Treat Vasculitides
  ClinicalTrials.gov Identifier: NCT00001473 - Completed
  Vasculitis; Wegener's Granulomatosis
  
• Improving the Quality of Patient Care by Using a Clinical Expert System.
  ClinicalTrials.gov Identifier: NCT00430755 - Recruiting
  Hypertension; Diabetes; Hypercholesterolemia; Vasculitis; Coronary Heart Diseases
  
• Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood Vessel Inflammation
  ClinicalTrials.gov Identifier: NCT00005928 - Completed
  Atherosclerosis; Coronary Disease; Vasculitis
  
• Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years
  ClinicalTrials.gov Identifier: NCT00307671 - Recruiting
  Vasculitis; Wegener’s Granulomatosis; Microscopic Polyangiitis; Churg-Strauss Syndrome; Polyarteritis Nodosa
  
• Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and Vasculitis
  ClinicalTrials.gov Identifier: NCT00293072 - Completed
  Systemic Lupus Erythematosus; ANCA Associated Vasculitis
  
• Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet`s Disease (INCYTOB)
  ClinicalTrials.gov Identifier: NCT00167583 - Recruiting
  Behcet`s Disease; Panuveitis; Posterior Uveitis; Retinal Vasculitis
  
• Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients with Wegener's Granulomatosis
  ClinicalTrials.gov Identifier: NCT00001761 - Completed
  Vasculitis; Wegener's Granulomatosis
  
• Treatment of Wegener's Granulomatosis with Cyclophosphamide
  ClinicalTrials.gov Identifier: NCT00001155 - Completed
  Vasculitis; Wegener's Granulomatosis
  
• Analysis of Bronchial Tissue and Fluid in Patients with Wegener's Granulomatosis
  ClinicalTrials.gov Identifier: NCT00001541 - Completed
  Inflammation; Vasculitis; Wegener's Granulomatosis
  
• Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory Conditions
  ClinicalTrials.gov Identifier: NCT00001764 - Completed
  Vasculitis; Wegener's Granulomatosis
  
• The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease
  ClinicalTrials.gov Identifier: NCT00331331 - Recruiting
  Uveitis; Vasculitis; Ocular Inflammatory Disease
  
• Etanercept to Treat Wegener's Granulomatosis
  ClinicalTrials.gov Identifier: NCT00001901 - Completed
  Vasculitis; Wegener's Granulomatosis
  
• Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases
  ClinicalTrials.gov Identifier: NCT00006055 - Active, not recruiting
  Purpura, Schoenlein-Henoch; Graft Versus Host Disease; Anemia, Hemolytic, Autoimmune; Rheumatoid Arthritis; Churg-Strauss Syndrome; ...
  
• Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated Vasculitides
  ClinicalTrials.gov Identifier: NCT00430105 - Completed
  ANCA Associated Systemic Vasculitis; Wegener's Granulomatosis; Microscopic Polyangiitis
  
• Intravenous Immunoglobulin After Relapse in Vasculitis
  ClinicalTrials.gov Identifier: NCT00307658 - Terminated
  ANCA + Vasculitides Relapsing Either Under Corticosteroid; and Immunosuppressant Therapies or After One Year; Post Treatment.